Article Details

GSK, Alector to co-develop antibodies for neurodegenerative diseases

Retrieved on: 2021-07-05 09:07:08

Tags for this article:

Click the tags to see associated articles and topics

GSK, Alector to co-develop antibodies for neurodegenerative diseases. View article details on hiswai:

Excerpt

GlaxoSmithKline (GSK) and Alector have partnered to co-develop and commercialise two clinical stage monoclonal antibodies for neurodegenerative ...

Article found on: www.pharmaceutical-business-review.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up